» Articles » PMID: 10548507

Basic Fibroblast Growth Factor Induces Osteoclast Formation by Reciprocally Regulating the Production of Osteoclast Differentiation Factor and Osteoclastogenesis Inhibitory Factor in Mouse Osteoblastic Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1999 Nov 5
PMID 10548507
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Basic fibroblast growth factor (bFGF) induced osteoclast formation in co-cultures of mouse spleen cells and osteoblasts. Osteoclastogenesis inhibitory factor (OCIF) and a selective cyclooxygenase-2 (COX-2) inhibitor, NS-398, abolished bFGF-induced osteoclast formation. bFGF did not affect spleen cells, but it did affect osteoblasts, to stimulate osteoclast formation. Northern blot analysis revealed that bFGF up-regulated the expression of osteoclast differentiation factor (ODF) and COX-2 and down-regulated the expression of OCIF in primary osteoblastic cells. NS-398 abolished the increase of ODF mRNA, but it had no effect on the decrease of OCIF mRNA. NS-398 suppressed the binding of (125)I-labeled OCIF to osteoblastic cells treated with bFGF. Enzyme-linked immunosorbent assay showed that bFGF inhibited OCIF production by osteoblastic cells, and the inhibition was not affected by NS-398. We conclude that bFGF induces osteoclast formation by stimulating ODF production through COX-2-mediated prostaglandin synthesis and by suppressing OCIF production through a mechanism independent of prostaglandin synthesis.

Citing Articles

Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.

Nakamura Y Cells. 2021; 10(7).

PMID: 34203430 PMC: 8305614. DOI: 10.3390/cells10071617.


Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.

Carrillo-Lopez N, Martinez-Arias L, Fernandez-Villabrille S, Ruiz-Torres M, Dusso A, Cannata-Andia J Calcif Tissue Int. 2021; 108(4):439-451.

PMID: 33586001 DOI: 10.1007/s00223-020-00803-2.


Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.

Imada M, Yagyuu T, Ueyama Y, Maeda M, Yamamoto K, Kurokawa S PLoS One. 2019; 14(2):e0211928.

PMID: 30735554 PMC: 6368314. DOI: 10.1371/journal.pone.0211928.


Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.

Jin L, Nonaka Y, Miyakawa S, Fujiwara M, Nakamura Y Mol Ther. 2016; 24(11):1974-1986.

PMID: 27506449 PMC: 5154475. DOI: 10.1038/mt.2016.158.


Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.

Kuroyanagi G, Otsuka T, Yamamoto N, Matsushima-Nishiwaki R, Nakakami A, Mizutani J Int J Mol Sci. 2014; 15(10):17886-900.

PMID: 25290095 PMC: 4227195. DOI: 10.3390/ijms151017886.